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1. ABSTRACT
Background: Shwachman-Diamond syndrome (SDS) is a rare autosomal 
recessive disorder in which the cardinal symptoms arise from exocrine 
pancreatic insufficiency and bone marrow dysfunction. Previous studies 
have suggested increased risk of fatal complications among Finnish SDS 
infants. The genetic defect responsible for the disease was recently iden-
tified; the SBDS gene is located at chromosome 7q11 and encodes a pro-
tein of unknown function. The discovery of the SBDS gene has opened 
new insights into the pathogenesis of this multiorgan disease.
Objective: This study aimed to assess phenotypic and genotypic features 
of Finnish patients with SDS.
Methods: Seventeen Finnish patients with a clinical diagnosis of SDS were 
included in the study cohort. Extensive clinical, biochemical, and imag-
ing assessments were performed to elucidate the phenotypic features, 
and the findings were correlated with the SBDS genotype. Imaging stud-
ies included abdominal magnetic resonance imaging (MRI), brain MRI, 
cardiac echocardiography including tissue Doppler examination, and 
cardiac MRI. The skeletal phenotype was assessed by dual-energy X-ray 
absorptiometry (DXA) and bone histomorphometry. 
Results: Twelve patients had mutations in the SBDS gene. In MRI, a char-
acteristic pattern of fat-replaced pancreas with occasional enhancement 
of scattered parenchymal foci and of pancreatic duct was noted in the 
SBDS mutation-positive patients while the mutation-negative patients 
did not have pancreatic fat accumulation. The patients with SBDS mu-
tations had significantly reduced bone mineral density associated with 
low-energy peripheral fractures and vertebral compression fractures. 
Bone histomorphometry confirmed low-turnover osteoporosis. The pa-
tients with SBDS mutations had learning difficulties and smaller head 
size and brain volume than control subjects. Corpus callosum, cerebel-
lar vermis, and posterior fossa structures were significantly smaller in 
SDS patients than in controls. Patients with SDS did not have evidence 
of clinical heart disease or myocardial fibrosis. However, subtle diastolic 
changes in the right ventricle and exercise-induced changes in the left 
ventricle contractile reserve were observed.
ABSTRACT
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Conclusions: This study expanded the phenotypic features of SDS to in-
clude primary low-turnover osteoporosis and structural alterations in the 
brain. Pancreatic MRI showed characteristic changes in the SBDS muta-
tion-positive patients while these were absent in the mutation-negative 
patients, suggesting that MRI can be used to differentiate patients har-
boring SBDS mutations from those without mutations. No evidence for 
clinical cardiac manifestations was found, but imaging studies revealed 
slightly altered myocardial function that may have clinical implications. 
These findings confirm the pleiotropic nature of SDS and underscore the 





Shwachman-Diamond syndrome (SDS, MIM # 260400), also known 
as congenital lipomatosis of the pancreas, Shwachman syndrome or 
Shwachman-Bodian-Diamond syndrome, is an autosomal recessive dis-
order that was recognized as a clinical entity in the early 60’s. Harry 
Shwachman, Louis Diamond, Frank Oski, and Kon-Taik Khaw, from 
Harvard Medical School, Boston, reported a new syndrome consisting 
of pancreatic insufficiency and neutropenia (Shwachman et al. 1963, 
Shwachman et al. 1964). They concluded that ”patients with unex-
plained neutropenia should be evaluated for pancreatic function, and 
patients with the diagnosis of cystic fibrosis in the presence of normal 
sweat electrolytes and lack of respiratory disease should be re-evaluated. 
This disease appears to have a much better prognosis than cystic fibrosis, 
and the two conditions should be carefully separated” (Shwachman et 
al. 1964). 
The clinical features of SDS include involvement of multiple organ sys-
tems that are not directly linked to each other. Exocrine pancreatic in-
sufficiency is a characteristic gastrointestinal manifestation; in the de-
veloped countries, SDS is the second most common cause of pancreatic 
insufficiency in children after cystic fibrosis. The hematological features 
link SDS to inherited bone marrow failure syndromes; it is thought to be 
the third most common inherited blood dyscrasia after Fanconi anemia 
and Diamond-Blackfan anemia. The bone involvement with metaphyseal 
chondrodysplasia associates SDS with skeletal dysplasias, a heterogene-
ous group of diseases with abnormalities in the skeletal development. 
The recent discovery of disease-causing mutations in the SBDS gene has 
lead to growing understanding of the genetic and molecular basis of 
SDS. Moreover, genotypic characterization of an increasing number of 
patients has enabled more precise phenotypic definition of this variable 
disorder. As stated in 1964 by Shwachman et al. (Shwachman et al. 1964): 
“With identification of more patients with this clinical entity, it is hoped 
that the complexities of etiology and interrelationship of the various 
aspects of the syndrome will be resolved.”
INTRODUCTION
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3. REVIEW OF THE LITERATURE
3.1. Shwachman-Diamond syndrome
3.1.1. History 
In 1964, Shwachman et al. described six American children, three of whom 
were initially thought to suffer from atypical cystic fibrosis (Shwachman 
et al. 1964). The children presented with failure to thrive, pancreatic 
insufficiency, neutropenia, growth retardation, absence of pulmonary 
disease and normal sweat electrolytes, elevated fetal hemoglobin levels, 
and mild galactosuria. Three of these patients were siblings, suggest-
ing inherited cause for the disorder. In the same year, Martin Bodian, 
Wilfried Sheldon, and Reginald Lightwood from The Hospital for Sick 
Children, London, reported two patients and reviewed the literature 
of 18 autopsy-proven cases of “congenital lipomatosis of the exocrine 
pancreas”, thus identifying the characteristic pancreatic histopatho-
logical feature of this newly recognized syndrome (Bodian, Sheldon & 
Lightwood 1964).
After these first cases, several small and large cohort studies from differ-
ent centers around the world further elucidated the clinical characteristics 
of this rare disorder (Table 1) which was first named after Shwachman. 
In 1980, an extensive study of phenotypic and histopathological features 
of British patients with SDS was published (Aggett et al. 1980). The in-
creased prevalence of leukemia in SDS was soon noted (Woods et al. 
1981). Savilahti’s group reported fatal myocardial involvement among 
Finnish children with SDS (Savilahti & Rapola 1984), a constant defect 
in neutrophil locomotion (Ruutu et al. 1984), and aberrant phagocyte 
function (Repo, Savilahti & Leirisalo-Repo 1987). In 1996, a wide spec-
trum of phenotypic abnormalities among Canadian patients with SDS 
was described but exocrine pancreatic dysfunction was an invariable ab-
normality (Mack et al. 1996). The same year, the risk of leukemic trans-
formation in SDS patients was shown to be considerably higher than 
previously thought and clonal aberrations to be frequent (Smith et al. 
1996). Immunologic dysfunction associated with SDS was also reported 
(Mäki et al. 1978, Aggett et al. 1980, Dror et al. 2001). In 1999, the report 
of a large international cohort of 88 SDS patients suggested autosomal 
recessive mode of inheritance and described varied phenotypic features 
as well as clinical presentation changing with age (Ginzberg et al. 1999). 
Further evidence for recessive inheritance was provided by segregation 
analysis of the families in this large international cohort (Ginzberg et al. 
2000). Linkage and haplotype analyses of the families and affected indi-










































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































viduals with SDS identified a single gene locus at the centromeric region 
of chromosome 7 (Goobie et al. 2001). In 2003, the gene involved in SDS 
was discovered (Boocock et al. 2003). Thereafter, several disease-causing 
mutations have been identified in this Shwachman-Bodian-Diamond 
gene, SBDS (Nicolis et al. 2005, Costa & Santos, 2008).
Skeletal involvement with metaphyseal dysplasia and delayed bone age 
affecting a subset of patients with SDS was recognized in several early 
reports (Burke et al. 1967, Fellman, Kozlowski & Senger 1972, McLennan 
& Steinbach 1974, Aggett et al. 1980, Mack et al. 1996, Ginzberg et al. 
1999). A radiographic study on Canadian SBDS mutation-verified pa-
tients in 2004 was able to show that skeletal changes are, in fact, present 
in all patients with SDS and SBDS mutations, but their severity and locali-
zation varies with age (Mäkitie et al. 2004). Lack of genotype-phenotype 
correlation was demonstrated in the skeletal (Mäkitie et al. 2004), he-
matological (Kuijpers et al. 2005), and clinical features in SDS (Kawakami 
et al. 2005).
Current research is focusing on the definition of the full clinical spec-
trum of SDS and on the deeper understanding of its etiopathogenesis as 
well as the molecular and the biological aberrations behind this disease. 
The elucidation of the underlying impairment in biological pathways, in 
turn, could allow for development of molecular therapeutic applications 
in the future.
REVIEW OF THE LITERATURE
3.1.2. Genetics and molecular basis of Shwachman-Diamond 
syndrome
Shwachman-Bodian-Diamond gene, SBDS, that lies in the long arm of chro-
mosome 7 at the cytogenetic position 7q11 (Boocock et al. 2003) is com-
posed of 5 exons and has a 1.6 kb mRNA transcript. The gene resides in a 
block of genomic sequence that is locally duplicated resulting in two ver-
sions of the SBDS: the functional gene and its non-functional pseudogene 
that is 97% identical with the functional gene. The genetic material from 
the pseudogene, pSBDS, contains errors that, when introduced into the 
SBDS gene, result in the disruption of the gene’s instructions to make a 
protein, SBDS. Gene conversion mutations resulting from an exchange of 
genetic material between the SBDS gene and the nearby pseudogene at 
meiosis have been found in 89% of individuals with SDS, with 60% having 
two converted alleles (Boocock et al. 2003). Two gene conversion muta-
tions predominate. A splice-site mutation 258+2T>C (hypomorphic allele) 
changes a single DNA nucleotide in intron 2. The other common mutation, 
183-184TA>CT (null allele), changes two nucleotides in the SBDS gene and 
introduces a premature stop signal in the instructions for making the SBDS 
protein. While heterozygosity for the hypomorphic and null alleles and ho-
14 REVIEW OF THE LITERATURE
mozygosity for the hypomorphic allele are the most common mutations in 
patients with SDS, no patients have been found homozygous for the null 
allele. Homozygous 183-184TA>CT mutations and, consequently, complete 
absence of the SBDS protein product are thus believed to result in early 
embryo lethality which is also seen in the animal model (Zhang et al. 2006). 
The mouse ortholog for SBDS has been shown to express ubiquitously in the 
majority of embryonic and adult mouse tissues, but increased expression is 
found in rapidly proliferating cells (Zhang et al. 2006).
The SBDS gene encodes a protein of 250 amino acids, SBDS. SBDS belongs to 
a highly conserved protein family and its wide occurrence in all archaea and 
plants indicates a fundamental role in cellular biology (Shammas et al. 2005). 
The exact function of SBDS protein, however, is to be defined. SBDS localizes 
within the nucleus and the cytoplasm; the protein shuttles in and out of the 
nucleus during cell cycles (Austin, Leary & Shimamura 2005). SBDS-deficient 
cells have been demonstrated to undergo accelerated apoptosis (Dror et al. 
2002, Rujkijyanont et al. 2008). Defects in SBDS protein are associated with 
mitotic spindle destabilization and genomic instability in bone marrow cells 
of the patients with SDS (Austin et al. 2008). Recent studies have revealed 
underlying impairment of ribosomal biogenesis in SDS, linking this disorder 
to other diseases with ribosomal dysfunction such as Diamond-Blackfan ane-
mia, dyskeratosis congenita, and cartilage-hair hypoplasia (Ganapathi et al. 
2007, Menne et al. 2007, Ganapathi & Shimamura 2008).
Almost 90% of the patients who meet the current diagnostic criteria for SDS 
have mutations in SBDS (Boocock et al. 2003). Hitherto, more than 50 muta-
tions in the gene have been identified (Boocock et al. 2003, Nakashima et 
al. 2004, Nicolis et al. 2005, Costa & Santos 2008). Most of these mutation-
positive patients (up to 60%) are compound heterozygotes of the two com-
mon conversion mutations (Boocock et al. 2003). Others carry a common 
mutation on one chromosome and either a rare mutation on the second 
chromosome or no identified mutations. However, in a subset of patients 
with a clinical phenotype of SDS, no mutations can be found, even after 
extensive laboratory testing; the absence of identified mutations in SBDS 
has been reported in 11% (Boocock et al. 2003) to 18% (Woloszynek et al. 
2004) of the patients with a clinical diagnosis of SDS.
3.1.3. Epidemiology 
To date, approximately 500 cases of SDS have been described in the litera-
ture. The estimated incidence is 1/50.00-1/75.000, and the carrier frequency 
is estimated to be 1/110 (Goobie et al. 2001). Although the median age 
at diagnosis is 1 year, the age of diagnosis has ranged from a newborn 
baby to a middle-aged adult. The early studies by Shwachman et al. (1964) 
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and Aggett et al. (1980) demonstrated equal numbers of both sexes among 
affected individuals. Despite autosomal mode of inheritance, more recent 
studies have shown male predominance with male-female ratio from 1.7:1 
(Ginzberg et al. 1999) to 1.5:1 (Alter 2007). Patients with SDS have a high 
risk of developing hematologic malignancy; age-dependent cumulative 
probability of leukemia is estimated to be over 70%. The projected median 
survival age is 35 years. To date, there are no reports of solid tumours in 
patients with SDS (Alter 2007).
3.1.4. Clinical presentation
SDS is a clinical diagnosis and the current diagnostic criteria include the 
demonstration of both exocrine pancreatic insufficiency and bone mar-
row dysfunction (Table 2). The verification of SBDS mutations confirms 
a clinical diagnosis. However, a negative SBDS mutation result does not 
exclude SDS (Shimamura 2006). Classically, patients with SDS present in 
early infancy with failure to thrive, steatorrhea with voluminous fatty di-
arrhea, hematological disturbances, recurrent infections, and short stature. 
However, the condition is highly variable and several other organs may also 
be affected (Table 3). Furthermore, clinical features vary over time making 
the diagnosis at a later age more challenging.
TABLE 2. Current diagnostic criteria of Shwachman-Diamond syndrome:
I. Exocrine pancreatic dysfunction (at least one of the following):
  a. Abnormal quantitative pancreatic stimulation test
  b. Serum cationic trypsinogen below the normal range
  c.  Serum pancreatic isoamylase under 12U/L (after 3 years of age)*
  d. Abnormal 72-hour fecal fat analysis plus normal intestinal biopsy
  e. Abnormal fecal elastase
II. Hematological abnormalities (at least one of the following):
 1. Chronic single lineage or multilineage cytopenia: 
  a. Neutropenia; repeated count  <1500 X 106/l
  b. Hemoglobin concentration < 2 SD 
  c. Thrombocytopenia <150 X 109/l
 2. Myelodysplastic syndrome





*(Ip  et al. 2002)
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Exocrine pancreatic insufficiency is one of the diagnostic hallmarks and 
an invariable feature of SDS (Shwachman et al. 1964, Mack et al. 1996). 
Histological specimens of the pancreas have revealed extensive fatty re-
placement of pancreatic acini with preserved islets of Langerhans and duc-
tal architecture (Bodian, Sheldon & Lightwood 1964, Aggett et al. 1980). 
Pancreatic dysfunction is usually diagnosed within the first six months of life 
and in 90% of the patients during the first year (Mack et al. 1996). Ductular 
electrolyte and fluid secretion has been shown to remain normal, but the se-
cretion of proteolytic enzymes is severely decreased leading to steatorrhea 
(Hill et al. 1982, Mack et al. 1996). The exocrine function of the pancreas 
ameliorates with increasing age in some patients. In cross-sectional and lon-
gitudinal data nearly 50% of the patients showed improved fat absorption 
and near normal fecal fat balance by the age of 4 years. Despite the relief 
in subjective symptoms, all patients had a persistent deficit of enzyme secre-
tion in quantitative studies on pancreatic function (Mack et al. 1996). 
Fecal elastase 1 test has been used to rule out pancreatic insufficiency in 
SDS. An abnormal test result, however, should be interpreted with caution 
because malabsorption, due to other reasons, may give erroneous results 
(Beharry et al. 2002). Serum trypsinogen and isoamylase levels have been 
shown to be more useful markers for pancreatic dysfunction in SDS (Ip et al. 
2002). In patients under 3 years of age, low trypsinogen level reliably indi-
cates exocrine pancreatic dysfunction. In this age group, isoamylase meas-
urement is less useful due to overlapping with the values for healthy young 
children. In a significant number of patients, serum trypsinogen values nor-
malize after the first years of life but isoamylase level remains constantly 
low. Therefore, serum isoamylase measurement provides a useful parameter 
to assess pancreatic function in patients over 3 years (Ip et al. 2002).
Endocrine function of the pancreas is generally unaffected in SDS. However, 
both children and adults with type 1 and type 2 diabetes mellitus have occa-
sionally been reported (Shmerling et al. 1969,Aggett et al. 1980, Mack et al. 
1996, Ginzberg et al. 1999, Filippi et al. 2002, Mäkitie et al. 2004, Kawakami 
et al. 2005, Kawashima et al. 2006, Rosendahl et al. 2006), even a rare form of 
neonatal-onset diabetes mellitus has been described (Kamoda et al., 2005).
Hematological features 
Hematological abnormalities are the diagnostic cornerstones for SDS. The 
most frequent abnormality is neutropenia that occurs in 88-100% of the pa-
tients (Aggett et al. 1980, Mack et al. 1996, Ginzberg et al. 1999). Neutropenia 
can be either persistent or intermittent, with fluctuation from normal to se-
verely low cell count levels. In about two thirds of the patients, neutropenia 
is intermittent, in the remaining patients it persists. Normochromic anemia 
with low reticulocyte count is encountered in 80%, and thrombocytopenia 
REVIEW OF THE LITERATURE
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occurs in 24-88% of the patients with SDS (Dror & Freedman 2002, Dror 
2005). Cytopenias affecting all three cell lines are seen 10-65% of the pa-
tients, occasionally resulting in severe bone marrow aplasia (Kuijpers et al. 
2004, Dror 2005). 
Bone marrow features in SDS are variable; bone marrow is usually hypocel-
lular with increased fat deposition (Aggett et al. 1980, Dror & Freedman 
1999), but it may occasionally be hypercellular or normocellular (Smith et 
al. 1996, Ginzberg et al. 1999); the bone marrow cell content does not nec-
essarily correlate with the peripheral cell counts. Accelerated angiogenesis 
with abnormal tortuous microvessels in bone marrow has been observed in 
SDS (Leung et al. 2006).
Patients with SDS are at risk of clonal bone marrow abnormalities and ma-
lignant transformation, particularly of acute myeloid leukemia (Aggett et 
al. 1980, Mack et al. 1996, Smith et al. 1996, Dror et al. 2005). Clonal chang-
es - most often monosomy 7, 7q deletion, isochromosome (7q), trisomy 8, 
and 20q deletion - may fluctuate and sometimes even become undetect-
able over time (Dror et al. 2002, Smith et al. 2002, Kuijpers et al. 2005). 
Isochromosome (7q) abnormalities, commonly seen in SDS but an uncom-
mon finding in other bone marrow failure syndromes, and 20q deletion 
do not seem to associate with malignant bone marrow transformation in 
SDS (Mellink et al. 2004). Current data suggest that trisomy 8 and chro-
mosome 7 abnormalities other than those involving isochromosome (7q) 
may contribute to leukemic progression in patients with SDS (Dror et al. 
2002, Smith et al. 2002). Males are excessively overrepresented among SDS 
patients with leukemic transformation; 92% of the reported SDS patients 
with leukemia are males (Dror et al. 2002). SDS-related leukemia has a poor 
prognosis. Patients with SDS usually fail to respond to chemotherapy and 
appear to have pronounced susceptibility to complications and organ tox-
icity in conjunction with stem cell transplantation; a recent review of 36 
reported patients revealed that 83% of the patients had succumbed from 
therapy-related complications (Dror 2005).
Infections and immunologic abnormalities
Patients with SDS are prone to recurrent infections of viral and bacterial ori-
gin, and the risk of fatal overwhelming sepsis, particularly at early age, is in-
creased (Grinspan & Pikora 2005). This susceptibility to infections is thought 
to result mainly from neutropenia, but serious infections may occur even 
in patients with protective neutrophil levels. While Aggett reported that a 
large number of patients had indeed suffered from recurrent infections at 
early age, he noticed that the severity and the frequency of infections did 
not correlate with the degree of neutropenia. However, the risk of both in-
fections and neutropenia tended to diminish over time (Aggett et al. 1980). 
REVIEW OF THE LITERATURE
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The most common reported infections in SDS are pneumonia (33%), recur-
rent otitis media (29%), and skin infections or skin abscesses (15%). Viral 
infections such as parvovirus, measles, and cytomegalovirus have also been 
observed in SDS. Paradoxically, fungal infections, hallmark infections of se-
vere neutropenia, have been reported in SDS only in conjunction with stem 
cell transplantation. (Grinspan & Pikora 2005).
Several immunologic abnormalities have been found in SDS. Defective neu-
trophil migration and chemotaxis are seen in most patients (Aggett et al. 
1979, Ruutu et al. 1984, Dror et al. 2001, Stepanovic et al. 2004), as well as 
aberrations in phagocyte function (Repo, Savilahti & Leirisalo-Repo 1987). 
Disturbances in both B and T cell functions have been reported (Hudson & 
Aldor 1970, Doe 1973, Mäki et al. 1978, Aggett et al. 1980, Dror et al. 2001). 
The observed T cell abnormalities include low percentage of total circulating 
T lymphocytes, CD3+CD4+ cell subpopulations, an inversed CD4:CD8 ratio, 
and low proliferative response. Decreased percentage of circulating natural 
killer cells has also been observed (Dror et al. 2001). B cell defects comprise 
low IgG or IgG subclasses, low percentage of circulating B lymphocytes, de-
creased in vitro B lymphocyte proliferation, and an inability to produce spe-
cific antibodies against polysaccharide antigens. This permanent inability to 
T cell-independent B cell responses, also called specific antibody deficiency, 
is seen in all clinically important antibody deficiencies (Bonilla et al. 2005). 
In its most severe forms, specific antibody deficiency closely resembles the 
clinical phenotype of the entity called common variable immunodeficiency. 
Recently, a 59-year-old male, treated with intravenous immunoglobulin for 
common variable immunodeficiency over 12 years was recognized to carry 
a heterozygous SBDS mutation (Khan et al. 2008). 
Skeletal manifestations
Compromised longitudinal growth leading to short stature is considered an 
integral feature of SDS. Patients may present with proportionate mild to 
moderate growth retardation which may be clinically evident even at birth 
(Shwachman et al. 1964, Bodian, Sheldon & Lightwood 1964, Aggett et al. 
1980, Mack et al. 1996, Ginzberg et al. 1999). The height deviation becomes 
more evident during early childhood and, despite adequate pancreatic 
enzyme supplementation, growth remains impaired and results usually in 
subnormal adult height (Ginzberg et al. 1999).  However, short stature can-
not be used to reliably establish a diagnosis because patients with normal 
height and weight have been described and half of the patients are within 
2 standard deviations (SD) of the normal mean for height (Mack et al. 1996, 
Ginzberg et al. 1999).
SDS-associated metaphyseal chondrodysplasia affecting the ribs and the 
knees was the first recognized skeletal feature (Burke et al. 1967). Other 
bone abnormalities were later described including delayed skeletal matu-
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ration and narrow rib cage which occasionally leads to thoracic dystrophy 
(Fellman, Kozlowski & Senger 1972, McLennan, Steinbach 1974, Danks et 
al. 1976, Aggett et al. 1980, Mack et al. 1996, Ginzberg et al. 1999). Electron 
microscopic examination of growth plate chondrocytes in SDS showed 
marked dilatation of rough endoplasmic reticulum and Golgi apparatus 
(Spycher et al. 1974). Systematic analysis of longitudinal radiographic data 
on 15 genetically confirmed patients revealed that skeletal abnormalities 
are present in all patients with SDS but the severity and the localization 
of bone changes vary with age and even with identical genotype (Mäkitie 
et al. 2004). SDS-associated skeletal dysplasia is characterized by delayed 
appearance but subsequent normal development of secondary ossification 
centers, and by variable metaphyseal widening and irregularity most of-
ten seen in the ribs and in the proximal and distal femora at early age. 
Although metaphyseal changes may become undetectable over time, they 
may also progress and result in knee and hip deformities (Mäkitie et al. 
2004). A recent case report described two children with SBDS mutations 
who presented with respiratory failure and severe skeletal abnormalities. In 
these severly affected children, the skeletal phenotype resembled spondy-
lometaphyseal dysplasia Sedaghatian type with markedly short stature, 
platyspondyly, megaepiphyses of the long bones, and severe metaphyseal 
changes (Nishimura et al. 2007).
In addition to skeletal dysplasia, generalized osteopenia and osteoporosis 
have occasionally been observed in children and adults with SDS (Nezelof & 
LeSec 1979, Aggett et al. 1980, Mäkitie et al. 2004, Rosendahl et al. 2006).
Liver involvement
Hepatic abnormalities have been described in about 50-75% of the patients 
(Brueton et al. 1977, Mäki et al. 1978, Liebman et al. 1979, Aggett et al. 
1980, Mack et al. 1996, Ginzberg et al. 1999). Liver involvement in SDS man-
ifests primarily in infancy with mild to moderate derangement in biochemi-
cal parameters of liver function, with or without hepatomegaly. However, 
even severe manifestations with massive hepatosplenomegaly and marked-
ly elevated liver enzyme levels have occasionally been described (Havlikova, 
Vychytil & Jelinek 1967, Wilschanski et al. 1994). Percutaneous liver biopsies 
and autopsy findings have shown micro- and macrovesicular hepatosteato-
sis, non-specific portal inflammation and variable periportal fibrosis in SDS 
(Bodian, Sheldon & Lightwood 1964, Aggett et al. 1980, Mack et al. 1996, 
Kuijpers et al. 2005). Like the symptoms of exocrine pancreatic insufficiency, 
hepatic involvement tends to regress with age. In one patient, necropsy 
findings six years after percutaneous liver biopsy suggested decrease of the 
fatty infiltration in the liver parenchyma over time (Aggett et al. 1980). 
Natural course of liver involvement in SDS is unknown, but in the majority 
of cases liver disease at early age is believed to be rather inconsequential 
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clinically. Patients with SDS, however, do appear particularly susceptible to 
organ toxicity, and liver failure in conjunction with induction for bone mar-
row transplantation has been described (Ritchie et al. 2002, Dror 2005).
Central nervous system involvement
Although cognitive function in SDS was initially reported normal 
(Shwachman et al. 1964), other early studies suggested variable cognitive 
impairment in some patients with SDS (Bodian, Sheldon & Lightwood 1964, 
Aggett et al. 1980). Mild to moderate developmental retardation or re-
duced IQ, or both, were noted in 85% of the patients studied by Aggett 
et al.(1980). Another study showed that patients with SDS had significantly 
lower IQ compared to their unaffected siblings and to the patients with 
CF (Kent, Murphy & Milla 1990). Subsequent studies have reported a wide 
variability in IQ (Mack et al. 1996) as well as developmental delay, atten-
tion deficit disorders, and learning difficulties in some patients (Cipolli et al. 
1999, Ginzberg et al. 1999). Preliminary findings in children with SDS and 
verified SBDS mutations suggest that affected children perform lower than 
their unaffected siblings and healthy controls in most cognitive domains 
(Kerr et al. 2005). 
Little is known about imaging features or histopathology of the brain in 
SDS. Hitherto, brain malformations in autopsy have not been described 
in SDS. Early reports describe pontine myelinolysis and focal pontine leu-
koencephalopathy in few patients with SDS who had succumbed due to 
sepsis (Steinsapir & Vinters 1985, Mah, Nelson & Vinters 1987, Anders et al. 
1993). Recently, delayed myelination on MRI in a neonate (Kamoda et al. 
2005), and agenesis of the corpus callosum on a CT scan of another infant 
(Todorovic-Guid et al. 2006) have been reported.
Cardiac manifestations
Fatal neonatal cardiac manifestations have been associated with SDS and 
with pancreatic lipomatosis in several early reports (Sacrez et al. 1969, 
Nivelon et al. 1978, Guerrero et al. 1979, Nezelof & LeSec 1979, Graham et 
al. 1980, Savilahti & Rapola 1984, Rybojad et al. 1996). In most of these cases 
histopathology has shown myocardial necrosis or fibrosis (Nezelof, Bouvier 
& Dijoud 2002). In a series of 16 Finnish patients with SDS, eight had de-
ceased with cardiomyopathy in early infancy. Autopsies showed, in addition 
to pancreatic lipomatosis, myocardial necrosis and/or left ventricular and in-
terventricular septum fibrosis but no signs of myocardial inflammation or 
coronary artery changes (Savilahti & Rapola 1984).
More recently, patients with SDS have appeared susceptible to excessive 
cardiac toxicity with stem cell transplantation (Tsai et al. 1990, Fleitz et al. 
2002, Donadieu et al. 2005, Dror 2005). Hitherto, the only observation of 
cardiomyopathy in SBDS-mutation verified patient is that of an adolescent 
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diagnosed with progressive dilated cardiomyopathy who was considered a 
candidate for heart transplantation by the age of 19 (Danesino et al. 2005).
Oral disease
Patients with SDS have high prevalence oral diseases. Extensive caries of 
both primary and permanent teeth and delayed dental maturation are 
common; up to 72% of the patients have tooth enamel defects ranging 
from hypomaturation to hypoplasia (Aggett et al. 1980, Ho et al. 2007). 
Periodontal disorders, such as recurrent oral ulcerations and gingival bleed-
ing are commonly seen in patients with SDS (Ho et al. 2007). 
Kidney involvement
Shwachman et al. reported unimpaired renal function but slight galactosuria 
in SDS (Shwachman et al. 1964), and variable glycosuria was noted in 50% of 
the patients in the study by Aggett et al. (1980). Subsequent studies, how-
ever, have not demonstrated glycosuria (Cipolli et al. 1999, Ginzberg et al. 
1999). Tubular acidosis, calciuria, nephrocalcinosis, urolithiasis and renal mal-
formations such as a duplex ureter have occasionally been observed (Aggett 
et al. 1980, Mack et al. 1996, Cipolli et al. 1999, Ginzberg et al. 1999). 
Skin manifestations
Skin involvement ranging from slight scaling of the skin to severe ichthyo-
sis has been observed in about 50% of the patients (Aggett et al. 1980, 
Savilahti & Rapola 1984). Skin lesions present at early age, sometimes even 
at birth, but they tend to improve and resolve after the first year of life 
(Savilahti & Rapola 1984). Skin biopsy has shown non-specific dermatitis 
(Liebman et al. 1979), and histological and ultrastructural analysis of the 
skin in  patients suffering from severe ichthyosis demonstrated marked dif-
fuse hyperkeratosis with variable parakeratosis, thickening of the granular 
layer, slight perivascular lymphocyte infiltration in the papillary dermis, and 
the presence of solitary or multiple droplets of varying size in the cytoplasm 
of the keratinocytes (Goeteyn et al. 1991, Rybojad et al. 1996).
Other organ involvement
Single cases of growth hormone deficiency (Kornfeld et al. 1995), hypogona-
dotropic hypogonadism (Raj et al. 2003), and hypothyroidism (Shimamura 
2006) have been observed in SDS. An autopsy report described testicular 
fibrosis and cardiomegaly in a child with SDS (Graham et al. 1980). 
Hirschsprung disease (Burke et al. 1967), ulcerative colitis (Ginzberg et al. 
1999) and mild intestinal villous atrophy (Mack et al. 1996) have been de-
scribed only in a few cases. Occasional observations of eye involvement such 
as strabismus, retinitis pigmentosa, coloboma and punctate keratitis have 
been reported (Aggett et al. 1980, Ginzberg et al. 1999)
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3.1.5. Differential diagnosis
The diagnosis of SDS is based on clinical diagnostic criteria of exocrine 
pancreatic and bone marrow dysfunction. Other diseases with similar 
clinical presentation should be excluded at the time of diagnosis. Celiac 
disease may sometimes mimic the clinical symptoms of SDS such as fail-
ure to thrive, diarrhea, short stature, and anemia. Sometimes patients 
with cow’s milk protein intolerance with erythematous skin rash and 
gastrointestinal symptoms may have similar early symptoms. Those pa-
tients, however, do not have exocrine pancreatic insufficiency. Cystic fi-
brosis (MIM # 602421), the most common cause for exocrine pancreatic 
insufficiency in the developed countries, can be excluded with repeated 
normal sweat chloride test results. Pearson syndrome (MIM # 557000) 
with exocrine pancreatic dysfunction, sideroblastic anemia and vacuoli-
zation of erythroid and bone marrow precursor cells is confirmed by 
the demonstration of mitochondrial DNA deletions. Johanson-Blizzard 
syndrome(MIM # 243800), also causing pancreatic insufficiency, can be 
excluded by typical phenotypic features that include congenital deaf-
ness, hypoplasia of alae nasi and scalp defects, and by genetic confirma-
tion. Various forms of severe congenital neutropenias maybe also be 
diagnostic alternatives. Other bone marrow failure syndromes such as 
Fanconi anemia (MIM # 227650) and Diamond-Blackfan anemia (MIM 
# 105650), may have to be considered; Fanconi anemia can be diag-
nosed with chromosomal breakage test. Cartilage-hair hypoplasia (MIM 
# 250250), another disease with underlying ribosomal dysfunction, 
presents with short stature and metaphyseal dysplasia, variable cytope-
nia and immunological deficiency; genetic defect lies in the RMRP gene 
at chromosome 9p21. 
3.1.6. Treatment and follow-up 
Pancreatic insufficiency is treated with pancreatic enzyme substitution 
with meals and snacks and with supplements for fat-soluble vitamins A, 
D, and E. With clinically improved pancreatic function over time, some 
of the patients may no longer require pancreatic enzyme substitution 
(Mack et al. 1996). 
Neutropenic patients with SDS and fever should be evaluated without 
delay and treated promptly with antibiotics bearing in mind the risks 
of serious, potentially life-threatening infections. Impaired neutrophil 
chemotaxis adds to the risk of infection beyond the low neutrophil 
count. Therefore, a patient with a severe chemotactic defect, even with 
a normal neutrophil count, may be at significant risk of infection (Dror 
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et al. 2001, Shimamura 2006). This should be taken into account even 
during minor dental or surgical procedures. Severe neutropenia in SDS 
has been successfully treated with low doses of granulocyte colony stim-
ulating factor, G-CSF (Donadieu et al. 2005). Leukofiltered red blood cell 
and thrombocyte transfusions have been used in cases of severe anemia 
or thrombocytopenia; leukofiltration reduces the risks of developing 
graft rejection after possible bone marrow transplant. 
Unlike pancreatic function, bone marrow involvement does not im-
prove with age, and stem cell transplantation is the only curative treat-
ment for bone marrow dysfunction in SDS (Dror 2005). However, due to 
transplantation-related organ toxicity and increased risk of refractory 
disease, the outcome of chemotherapy for SDS-related hematological 
malignancies is poor (Tsai et al. 1990, Fleitz et al. 2002, Donadieu et al. 
2005, Dror 2005). Preparative regimens that include cyclophosphamide 
and total body irradiation are associated with an increased risk of organ-
toxicity. Recently, reduced-intensity condition protocol has been shown 
to substantially improve transplantation outcome (Bhatla et al. 2008).
Detection of asymptomatic myelodysplastic syndrome with excess blasts 
and acute myeloid leukemia with low blast count may prompt early treat-
ment and improve prognosis. Therefore, in a stable patient with mild to 
moderate cytopenia, complete blood count and peripheral blood smear 
three to four times a year as well as annual bone marrow testing to look 
for occult transformation have been suggested. In cases of severe bone 
marrow aplasia and myelodysplastic syndrome, stem cell transplantation 
should be considered. (Shimamura 2006).
Bone deformities due to metaphyseal chondrodysplasia, usually located 
in the hips or the knees, may require surgical interventions. A single 
case report of bisphosphanate (alendronate) treatment for SDS-related 
osteoporosis describes an increase in bone mineral density (BMD) in an 
adult patient with several mutations in SBDS, severe growth failure, hy-
pophosphatemia and osteoporosis (Rosendahl et al. 2006).
Because multiple organ systems are affected in SDS, multidisciplinary ap-
proach to clinical care is expected to improve the treatment and quality 
of life of these patients.
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3.2. Imaging studies in the assessment of various 
body systems
3.2.1. Basic principles of imaging modalities
X-ray is a form of electromagnetic ionizing radiation which can be used 
in medical imaging for plain radiographs but also in other imaging mo-
dalities, such as dual-energy X-ray absorptiometry (DXA) and computed 
tomography (CT). DXA uses low doses of X-rays to assess BMD; the radia-
tion dose corresponds to approximately 10% of the dose of a standard 
chest X-ray. Two X-ray beams with different energy levels are aimed at 
the assessed area, and tissue absorption of each beam is recorded. CT is 
based on X-ray beams that pass through the patient from various direc-
tions: X-ray beam that has the shape of a thin fan rotates around the 
patient and detectors measure the intensity of the attenuated radia-
tion as it emerges from the body. The local attenuation is calculated at 
each point within the CT section with a mathematical image reconstruc-
tion, and these data are converted into a CT image. Multidetector-row 
CT (multislice CT) technique enables fast acquisition of image data in a 
short time and allows for three-dimensional imaging and multiplanar 
reformats. The radiation from a CT examination is considerably high; for 
example, radiation dose from an abdominal CT corresponds to that of 
400 standard chest X-rays. (Silverman & Kuhn 1993).
Sonography i.e. ultrasound is based on mechanical vibration that creates 
high frequency sound waves (usually 1-30 MHz). Brief bursts of ultra-
sound waves are transmitted into the body where they travel through 
tissues. Different tissues have different acoustic properties i.e. acoustic 
impedances. Whenever the sound pulse encounters an interface be-
tween tissues of different acoustic impedance, reflection or scattering of 
the sound occurs. As these echoes of the transmitted sound waves return 
to the receiver, an ultrasound image is generated. One of the important 
features of sonography is the lack of ionizing radiation. (Silverman & 
Kuhn 1993).
Magnetic resonance imaging (MRI) is based on signals obtained from the 
protons in the tissue hydrogen atoms within an external magnetic field. 
The protons possess an intrinsic spin and a positive electrical charge, 
and thus generate a small magnetic field. As the patient is placed into 
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a strong external field in the MRI scanner, all protons align with this 
external magnetic field; this is called longitudinal magnetization. After 
the application of an excitation radiofrequency energy pulse, a subset 
of protons that have the same frequency absorb energy and tilt to a 
higher energy level in a phenomenon called resonance and start to spin 
synchronously; this is called transverse magnetization. When the radiof-
requency energy pulse is turned off, the protons return to equilibrium 
and release their absorbed energy producing an MRI signal. Two mag-
netization relaxation processes can be used to characterize substances. 
First, the longitudinal magnetization will get back into original position; 
the time needed for the process is called longitudinal relaxation (T1) 
time. Secondly, as the protons move, they experience varying magnetic 
fields due to the surrounding environment. This causes a spread of reso-
nant frequencies and a dephasing of magnetization in the transverse 
plane. The time needed for this process is called transverse relaxation 
(T2) time. Both T1 and T2 values are tissue-specific and thus enable ef-
fective tissue characterization. MRI provides a versatile, non-invasive 
method that causes no radiation exposure and enables effective evalu-
ation of soft tissue organs and their disorders. Dynamic contrast-agent 
enhanced imaging allows for tissue characterization and assessment 
on vascular supply in different phases (e.g. arterial and venous phases). 
Heavily T2-weighted sequences produce high signal of stagnant fluid 
(e.g. fluid in the biliary system and pancreatic duct). Ultrafast sequences 
may be used for data collection during a single cardiac cycle. Advances in 
MRI technology have enabled the development of novel sequences and 
techniques, including three-dimensional volumetric imaging methods. 
(Bushberg et al. 2002).
Imaging in children presents special challenges in view of their greater 
sensitivity to radiation and, in younger age groups, of their lack of co-
operation. One important goal in pediatric imaging is to obtain diagnos-
tic information with the least amount of radiation exposure. Therefore, 
in pediatric imaging, ultrasound and MRI without radiation exposure 
are preferable modalities rather than CT with a high dose of ionizing ra-
diation. Disadvantages of MRI include the need for anesthesia in young 
children, its limited availability, and the financial cost.
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3.2.2. Pancreatic imaging
Sonography is considered the primary imaging modality of the pancreas 
in pediatric patients (Nijs, Callahan & Taylor 2005). Several reports de-
scribe hyperechogenic pancreas in patients with SDS (Robberecht et al. 
1985, Schneider, Harms & Fendel 1987, Berrocal et al. 1995, Adachi et al. 
2005). In young patients, however, sonography is insensitive to detect 
lipomatosis, and even entirely fatty pancreas can be overlooked (Adachi 
et al. 2005). CT can more reliably demonstrate lack of normal pancreatic 
tissue and its replacement by fat in SDS (Bom et al. 1993, Robberecht et 
al. 1985) but its major disadvantage is high dose of ionizing radiation.
MRI is an ideal technique for pancreatic imaging in both children and 
adults (Pamuklar & Semelka 2005). The use of MRI in detection of pan-
creatic involvement in SDS has been described in only a few reports (Bom 
et al. 1993, Lacaille et al. 1996, Ruggiero et al. 2008). On MRI, pancre-
atic parenchyma and fat can be detected with high specificity and sen-
sitivity. Advanced techniques such as chemical shift imaging (in-phase, 
out-of-phase imaging) even enable visualization of intracellular tissue 
fat accumulation of microscopic scale. Magnetic resonance cholangio-
pancreatography (MRCP) allows for precise non-invasive visualization of 
the biliary system and pancreatic duct morphology. Secretin-stimulated 
MRCP enables dynamic functional assessment of the pancreatic duct and 
improves visualization of the entire duct including its side branches as 
secretin increases exocrine production of fluid and bicarbonate in the 
pancreas (Brice 1999, Lee et al. 2006). 
3.2.3. Bone assessment
Conventional radiographs are the gold standard in the assessment of skel-
etal dysplasia and vertebral morphology (Genant et al. 1993, Mäkitie et 
al. 2005). 
DXA is the most widely used non-invasive method to measure BMD. It al-
lows for the quantification of bone mass and BMD and can also be used 
to measure total body composition and fat content. In DXA, bone mineral 
content (BMC), measured as the attenuation of the X-ray by the scanned 
bones, is divided by the area of the site being scanned to obtain areal BMD 
(g/cm2). Thus it does not measure true BMD, which is bone mass divided by 
bone volume (g/cm3). Despite problems with bone volume estimation, DXA 
is still a fairly accurate measure of BMC. T-score, the number of SD that an 
individual BMD measurement differs from the mean when a historical, 
sex-matched normal young adult population is used as the reference, has 
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proved useful in defining osteoporosis in adults (Genant et al. 1999).
With low radiation dose and short imaging time, DXA can be used to as-
sess bone mass also in young children (Njeh et al. 1997). Special consider-
ations must be taken into account when interpreting DXA measurements 
in pediatric population (Bishop et al. 2008). First, the comparison of BMD 
of a child to the adult reference data (T-scores) would lead to an overesti-
mation of bone mineral deficits, since children have less bone mass than 
adults. Therefore, children’s BMD scores are commonly compared with 
reference data for the same gender and age (Z-score). In addition to age, 
other variables such as bone size and bone maturation may confound 
the interpretation of DXA-derived BMD. Therefore, correction with bone 
age and lean tissue mass (LTM) have been proposed to obtain more ac-
curate and comparable BMD results in children (Högler et al. 2003). 
3.2.4. Brain imaging
MRI is the modality of choice for the evaluation of myelination, neuro-
degenerative disorders, and developmental malformations of the brain. 
However, individuals with intellectual disabilities of unexplained etiol-
ogy often have, in the visual assessment of MRI data, either unremark-
able or mild, non-specific findings (Decobert et al. 2005). More accurate 
computer-assisted measurements of different brain structures can reveal 
changes that are not detectable in the visual analysis (Ashburner et al. 
2003). 
Voxel-based morphometry is a fully automated computed method that 
allows for the segmentation of the imaging data voxel by voxel into dif-
ferent tissue types. With the voxel segmentation process, the volumes 
of gray and white matter as well as total brain volume and cerebrospi-
nal fluid volume can be accurately determined, and regional and glob-
al brain matter volume changes can be assessed (Ashburner & Friston 
2000). 
3.2.5. Cardiac imaging methods
 
Conventional echocardiography is an expedient non-invasive method 
to acquire baseline information on intracardiac anatomy, myocardial 
contractility, and diastolic function. However, basic functional measure-
ments may be insensitive to detect subtle changes in the systolic and 
diastolic properties of the heart. tissue Doppler velocity imaging has re-
cently been applied to measure the systolic ejection wave (S-wave) and 
isovolumic acceleration of the ventricular myocardium at the level of 
the mitral valve annulus. Isovolumic acceleration is sensitive to changes 
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in global contractility (Mori et al. 2000, Peteiro et al. 2002, Vogel et al. 
2003, Cheung et al. 2005). S-wave, on the other hand, is a manifestation 
of the ejection phase (Mori et al. 2000 Cheung et al. 2005). They both 
reflect myocardial contractility, and are depressed in children with con-
genital heart disease (Cheung et al. 2005). 
Compared to echocardiography, MRI can more precisely assess the right 
side of the heart, myocardium, and the pericardium (White & Patel 
2007). 3-D computer-based model as a quantitative segmentation tool 
in MRI image analysis yields accurate quantitative information on volu-
metric changes within different phases of the cardiac cycle (Lötjönen et 
al. 2004).
REVIEW OF THE LITERATURE
31
4. AIMS OF THE STUDY
The aims of the study were to assess
1. the clinical and genetic features 
2. the pancreatic phenotype and imaging findings
3. the prevalence and the nature of osteoporosis
4. the MRI characteristics of the brain, and
5. the cardiologic characteristics 
 of the Finnish patients with SDS.




5.1.1. Patients with Shwachman-Diamond syndrome
The pediatric and gastroenterological units of all university hospitals in 
Finland were contacted to obtain information on patients diagnosed 
with SDS or with features suggestive of SDS. Fourteen patients with a 
previous diagnosis of SDS were identified in Finland; the diagnosis was 
based on verified exocrine pancreatic insufficiency and hematological 
dysfunction (permanent or intermittent neutropenia with or without 
other hematological abnormalities) and on the exclusion of other pan-
creatic and hematological conditions with a phenotypic resemblance to 
SDS. One patient, a 50-year-old male, was unwilling to participate in the 
study. Thirteen patients consented and were subsequently invited to the 
out-patient clinic of the Hospital for Children and Adolescents, Helsinki 
University Hospital. Five adult patients in the present study, aged 24-37 
years, had been previously assessed as infants (Savilahti & Rapola 1984). 
In addition to the previously diagnosed patients, four children investi-
gated in our institution during the study in 2004-2007, who fulfilled the 
clinical criteria of SDS, were included. 
The Research Ethics Board, Helsinki University Hospital, approved the 
study protocol and written informed consent was obtained from each 
patient and/or guardian.
Study I: Pancreatic phenotype and abdominal MRI in Shwachman-
Diamond syndrome 
All patients with a clinical diagnosis of SDS who did not require anesthe-
sia for abdominal MRI were included in prospective abdominal MRI ex-
amination. In addition, clinically indicated abdominal MRI data which 
had been obtained under anesthesia in young patients prior to or at the 
time of the study were included. 
Study II: Evaluation of bone health in Shwachman-Diamond syn-
drome 
All patients with a clinical diagnosis of SDS and verified mutations in 
the SBDS gene, and over 4 years of age, in order to have the required 




Study III: Neuroradiological assessment of Shwachman-Diamond syn-
drome 
Patients with a clinical diagnosis of SDS and verified mutations in the 
SBDS gene, without history of brain damage or serious head trauma 
with loss of consciousness, and with age over 5 years in order to avoid 
anesthesia during the brain MRI, were included in the brain MRI study. 
Study IV: Myocardial function in Shwachman-Diamond syndrome 
Patients with SBDS mutation-verified SDS and over 6 years of age, in or-
der to enable pedal ergometry during tissue Doppler examination, were 
included in the study on cardiac features. Cardiac MRI was performed 
only on those patients who did not require anesthesia. 
5.1.2. Control subjects
Study III
For each patient with SDS, two healthy right-handed age- and gender-
matched hospital workers or their family members were ascertained for 
the control group of the brain MRI study. History of neuropsychological 
symptoms, systemic illnesses, antenatal or perinatal insults, or serious 
head trauma with loss of consciousness were excluded by patient/guard-
ian interview. Altogether 18 age- and gender-matched control subjects 
for nine patients with SDS underwent study protocol brain MRI in 2005-
2006. 
Study IV
The control group for tissue Doppler echocardiography consisted of 26 
healthy volunteers studied at the Hospital for Sick Children, Toronto, 
Canada in 2003-2004 using similar equipment and study protocol. All 
had normal cardiac structure and systolic function in baseline echocar-
diography. A family history of sudden death or prolongation of the cor-
rected QT interval was excluded by a patient/parent interview.
Control imaging data for the cardiac MRI were obtained from the previ-
ously reported examinations performed in 2002 on 12 healthy Finnish 
subjects without a history of diabetes, coronary artery disease, valvular, 
or hypertensive disease (Kivistö et al. 2004, Kivistö et al. 2006). The im-
aging protocol was similar to that used for the patients except for late 
enhancement sequence which was only obtained for the patients with 
SDS. The number and the age range of the patients and the controls are 
summarized in Table 4.
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TABLE 4. Numbers of patients with Shwachman-Diamond syndrome 
and controls that participated in the studies.
5.2. Assessment methods
5.2.1. Clinical, biochemical, and histomorphometric assessment
Clinical and auxological assessment
A detailed family history and history for growth and health, exercising 
habits, and medications including the use of pancreatic enzyme and vi-
tamin substitutions were obtained by patient/parent interview and from 
hospital records. Patients were clinically assessed for growth, puberty, as 
well as gastrointestinal and skeletal symptoms by a pediatrician. In addi-
tion, a pediatric cardiologist performed clinical cardiac assessment on all 
the patients who were included in Study IV. Height, weight and occip-
itofrontal head circumference (OFC) were measured; values were com-
pared with normative data (Sorva et al. 1990). Height and OFC SD scores 
(Z-scores) were defined as deviation, in SD units, from the mean value 
for age and sex (Sorva et al. 1990, Pere 2000). Weight was expressed as 















17 patients 2.1-37  Clinical diagnosis of SDS, exclusion of cystic 
fibrosis by sweat tests 
Study I 14 patients  2.1-37  Clinical diagnosis of SDS, no need for 
additional anesthesia in MRI 
Study II 11 patients 5.2-37 SBDS mutation-verified SDS, age >4 years 




SBDS mutation-verified SDS, age >5 years 
Healthy age- and gender-matched subjects 
Study IV 8 patients 
26 Echo-controls 




SBDS mutation-verified SDS, age >6 years 
Healthy volunteers examined in 2003-2004 







Peripheral blood counts were obtained to assess hematological dysfunc-
tion. Anemia was defined as a hemoglobin concentration below the nor-
mal age- and sex-specific reference range (Dallman & Siimes 1979), neu-
tropenia as a neutrophil count <1500 x 106 cells/L in repeated measure-
9
Serum concentrations of cationic trypsinogen (reference range 16.6 - 
45.6 µg/L) and pancreatic isoamylase activity (reference range 13 - 53U/L) 
were determined. The presence or absence of pancreatic insufficiency 
was classified on the basis of serum trypsinogen concentration (Moore 
et al. 1986, Ginzberg et al. 1999); patients with values <6 µg/L were clas-
sified as having pancreatic insufficiency and patients with intermediate 
(6 - 16.6 µg/L) or normal ( >16.6 µg/L) values were classified as having 
pancreatic sufficiency. Fecal pancreatic elastase 1(reference range >200 
µg/L) was quantified by ELISA (Pancreatic Elastase ELISA, Bioserv Analytics 
and Medical Devices Ltd. Rostock, Germany). Serum concentrations of 
25-OH-vitamin D (S-25-OHD), vitamin A using retinol (Sigma R-7632, UK) 
as standard and vitamin E using alfa-tocopherol (Sigma T-3634, UK) as 
standard were determined by HPLC followed by UV detection (HP 1100 
Liquid Chromatograph for 25-OHD and HP1090 Liquid Chromatograph 
for vitamins A and E). S-25-OHD values lower than 38 nmol/L were re-
garded consistent with hypovitaminosis D. The reference range for vita-
min A was 1-3 µmol/L and for vitamin E 12-40 µmol/L.
Plasma concentrations of alkaline phosphatase (reference range age-de-
pendent), aspartate aminotransferase (reference range <50 U/L), alanine 
aminotransaminase (reference range <40 U/L), gamma glutamyltrans-
ferase (reference range sex- and age-dependent), total bilirubin (refer-
ence range 5 - 25 µg/L), conjugated bilirubin (reference range <2 µg/L), 
creatinine (reference range 50 - 90 µg/L), phosphate (reference range 
age- dependent), prothrombin time (normal >70%), and serum concen-
trations of fasting bile acid (reference range <6µg/L), and base excess 
(reference range –2.5 - +2.5) were determined by standard assays.
Mutation analyses of the SBDS gene 
A blood sample for DNA extraction was obtained from the patient 
and the parents for mutational analysis of the SBDS gene. Mutational 
analyses of the DNA samples for 16 patients were performed in Dr. J. 
Rommens’ laboratory at the Hospital for Sick Children, Toronto, Canada. 
In one patient, mutational analysis was performed in Dr Shiro Ikegawa’s 
laboratory in Tokyo, Japan. SBDS coding regions were screened for mu-
tations by restriction enzyme digestion of amplified exon 2 or by direct 
sequencing of PCR amplified products of genomic DNA, as previously 
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described (Boocock et al. 2003). DNA samples of patients without two 
identified mutations in exon 2 underwent direct sequencing of all cod-
ing regions of the SBDS gene.
Bone histomorphometry
A transiliac bone biopsy for histological and histomorphometric studies 
was obtained from selected consenting patients with a bone biopsy nee-
dle with an inner diameter of 7.5 mm (Rochester Bone Biopsy, Medical 
Innovations Incorporation Inc, USA) following a double-labeling course 
with oral tetracycline, with a 10-day interval period. The biopsy was per-
formed four days after the end of tetracycline administration. Analyses 
for bone histomorphometry were conducted at the Bone and Cartilage 
Research Unit, University of Kuopio, Kuopio, Finland. All parameters 
were analyzed using a semiautomatic image analyzer (Bioquant Osteo, 
Bioquant Image Analysis Corporation, Nashville, TN, USA) and the re-
sults were compared with normative data (Glorieux et al. 2000, Recker 
et al. 1988, Rehman et al. 1994). All nomenclature, abbreviations, and 
standard formulas follow the recommendations of the American Society 
for Bone and Mineral Research.
5.2.2. Radiographic, bone densitometric, and echocardio-
graphic assessment
Radiographs
Radiographic assessment included plain radiographs of the chest (pos-
terior-anterior and lateral views), thoracic and lumbar spine (anterior-
posterior and lateral views), pelvis (anterior-posterior view), knees 
(anterior-posterior view), and the hands (anterior-posterior view). All 
radiographs were reviewed by two radiologists, and skeletal abnormali-
ties were recorded. Thoracic and lumbar radiographs were assessed and 
changes in vertebral morphology were graded by inspection of digitized 
images (AGFA ImPacs System). The grading methods of Genant (Genant 
et al. 1993) for adults and of Mäkitie (Mäkitie et al. 2005) for children 
were used to identify vertebral morphological changes suggestive of os-
teoporosis. Compression of more than 20% in the anterior, middle, or 
posterior vertebral height was considered significant. 
Bone Densitometry
Areal BMD for the lumbar spine (L1-L4), proximal femur, and the whole 
body were measured with DXA (Hologic Discovery A, Bedford, USA). 
The areal BMDs were transformed into Z-scores by using age- and sex-
specific reference data for the equipment. In addition, T-scores were 
calculated for adult patients by comparing the areal BMD results with 
sex-specific reference data for the equipment. Body composition, includ-
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ing BMC, fat mass and LTM, was obtained with the same DXA scanner. 
Height-adjusted Z-scores for BMC/LTM were calculated using previously 
published reference data for children and young adults (Högler et al. 
2003).
Echocardiography with tissue Doppler assessment
ECG was recorded at rest and baseline echocardiography (Acuson Sequoia 
512 Siemens, Mountain View, CA) was performed. The study subject was 
then exercised for the tissue Doppler examination on the cycle ergom-
eter by increasing resistance of the pedals by 15-25 W at intervals of 1-2 
minutes in order to achieve, during each interval, an increase in heart 
rate of 20 beats/min from the previous level; the target heart rate was 
160 beats/min. The heart was imaged through an apical four-chamber 
view with the most optimal angle to the left ventricle free wall; myo-
cardial velocities of the left ventricular basal free wall were measured 
as previously described with simultaneous ECG recording (Vogel et al. 
2003). The left ventricle Tei-index that describes combined systolic and 
diastolic function was derived from the Doppler-measurements (Tei et al. 
1995). The left ventricular rate-corrected velocity of circumferential fiber 
shortening was calculated as previously described (De Wolf et al. 1998). 
The acquired tissue velocity data were analysed using Echopac software 
(GE Medical Systems, GE Vingmed Ultrasound AS, Horten, Norway). 
Isovolumic acceleration and the systolic wall movement velocity were 
measured during tissue Doppler echocardiography from a minimum of 
three cardiac cycles and averaged (Vogel et al. 2003).
5.2.3. MRI assessments
Abdominal MRI 
The prospective MRI studies were performed with three 1.5 T scanners 
(Philips Intera Achieva for the children, and Siemens Sonata and Vision 
for the adults). Imaging protocol included axial images of the upper 
abdomen with gradient echo sequence (FFE/TrueFISP)-, fat-saturated 
T1 (T1 fs)- and fat-saturated T2 (T2 fs)-weighted images, gadolinium-
enhanced (intravenous Dotarem 279.3 mg/mL, 0.2 mL/kg) fat-saturated 
T1-weighted (THRIVE/VIBE) images at arterial, venous and late venous 
phases, chemical shift (in-phase/opposed-phase) imaging, MRCP se-
quence, and, in four adult patients, secretin-stimulated MRCP images 
after intravenous administration of secretin (Secrelux, Goldham Bioglan, 
Zusmarshausen, Germany, 1 IU/ kg body weight). 
All prospective and previously performed MRI studies were reviewed in-
dependently by two radiologists who were blinded to the genetic find-
ings. The final conclusions were reached by consensus. The size of the 
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pancreas was graded as small, normal or enlarged visually and using 
previously reported measurements for age (Heuck et al. 1987). Signal 
intensity, parenchymal structure, ductal anatomy, and contrast enhance-
ment of the pancreas were assessed. The presence or the absence of 
identifiable pancreatic tissue was recorded.
Brain MRI
The patients and their matched controls underwent brain MRI with the 
same 1.5T imager (Philips Intera Achieva). T2-weighted axial and coro-
nal slices with a turbo-spin-echo sequence (TR 5000 ms, TE 100 ms, slice 
thickness 3 mm), an axial fluid-attenuated inversion recovery (FLAIR) se-
quence (TR 11000 ms, TE 140 ms, IR 2800 ms, slice thickness 4 mm), and a 
3-dimensional magnetization-prepared rapid acquisition gradient echo 
(3D MPRAGE) sequence (TR 25 ms, TE 4.6 ms, flip angle 30º, slice thick-
ness 1 mm) were obtained.
An experienced neuroradiologist who was blinded to the subjects’ geno-
type assessed all T2-weighted and FLAIR images for visually detectable 
brain changes. The brain signal intensities, gray-white matter differen-
tiations, the sizes of the ventricles and cortical cerebrospinal fluid spaces 
were recorded. 3D MPRAGE image data were segmented into white 
matter, gray matter, cerebrospinal fluid, and non-brain tissues, using au-
tomated segmentation method (SPM2 software package, available at 
http://www.fil.ion.ucl.ac.uk/spm/). After segmentation, the volumes of 
global brain matter, white matter, gray matter, and cerebrospinal fluid 
were automatically calculated for each studied subject.
Midsagittal MRI slice was defined by the visualization of cerebral aque-
duct. Midsagittal areas of internal skull surface, cerebral surface, pos-
terior fossa surface, vermis, mesencephalon, pons, medulla, the length 
and the surface area of corpus callosum, and the midsagittal diameters 
of genu, body and splenium of corpus callosum, and of mesencephalon, 
pons, and medulla were measured by a radiologist from 3D MPRAGE 
sagittal images (Figure 1 A) with a digital radiological work station 
(Agfa Impax) measurement tools (Hashimoto et al. 1993, Laissy et al. 
1993, Raininko et al. 1994). The following ratios were calculated from 
the midsagittal area measurements: posterior fossa/vermis, cerebrum/
vermis, cerebrum/corpus callosum. The bifrontal ratio, obtained from 
the ratio of the longest distances of the anterior horns of lateral ventri-
cles at the level of the third ventricle and the brain width at the same 
level (Aylward et al. 1991), was calculated from T2-weighted axial im-
ages (Figure 1 B). 
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FIGURE 1. Brain MRI measurements.
A. Midsagittal areal measurements from a 3D MPRAGE (TR 25 ms, TE 4.6 ms, flip angle 
30°, 1 mm slice) sagittal image. CC, corpus callosum; ME, mesencephalon; M, medulla; P, 
pons; V, vermis. b, callosal body; g, callosal genu; s, callosal splenium, t, cerebellar tonsil. 
B. The measurement of bifrontal ratio (a-b distance/c-d distance) from an axial TSE T2 (TR 
5000 ms, TE 100 ms image, 3 mm slice) image. 
Cardiac MRI
Cardiac MRI was performed with a 1.5T MRI imager (Philips Intera 
Achieva) using a cardiac coil. To assess cardiac anatomy and function, 
cine images were obtained with an ECG-gated breath-hold balanced TFE 
sequence (TR 3.27 ms, TE 1.63 ms, flip angle 60º) which produces a series 
of images within the cardiac cycle every 40 ms. All cine sections were 
acquired at the same end-expiration phase to minimize the effects of 
respiratory variation. The heart was covered from ventricular base to 
apex with two- and four-chamber views, and short-axis sections of 8 mm 
thickness 8 mm apart. Late enhancement images at the same sections 
were obtained to assess myocardial fibrosis 15 minutes after intrave-
nous Gadolinium-DTPA-BMA (Dotarem 0.15 mmol/kg) with IR balanced 
FFE pulse sequence (TR 3.53 ms, TE 1.72 ms, section thickness 6 mm). 
Inversion time was individually set to null signal from normal myocar-
dium (250-300 ms). 
The long- and short- axis cine images were used to obtain accurate de-
scription of cardiac anatomy and function. Atrial and ventricular volumes 
and the left ventricular mass were semi-automatically segmented from 
each frame of the cine MRI data (Figure 2) using a three-dimensional 
segmentation method developed for this purpose (Lötjönen et al. 2004). 
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The largest and the smallest volumes of the atria and cyclic atrial volume 
changes were determined (Järvinen et al. 1994). End diastolic and end 
systolic volumes, stroke volume and ejection fraction, the maximal slope 
during diastole (=peak filling rate) and the volume change from early 
diastole to the peak filling rate (=early diastolic filling) of both ventricles 
were determined. The left ventricle mass and the ventricular volumes 
were adjusted for body surface area. The myocardial wall enhancement 
was visually analyzed by two radiologists. 
FIGURE 2. Volumetric assessment of cardiac MRI data.
A-B. Slices of the two-chamber and the four-chamber view of the heart obtained with 
cardiac MRI cine images (Balanced TFE sequence, TR 3.27 ms, TE 1.63 ms, flip angle 
60°, 8 mm slice). Each compartment is outlined for volumetric assessment of the atria 
and the ventricles
5.3. Statistical analyses
Studies I and II: Simple regression analysis, Student’s paired t-test, and Chi 
square test were used, as appropriate, for statistical analysis (Statview 5.0.1 
for Macintosh, 1992-1998 SAS Institute Inc., USA). A P-value of less than 0.05 
was considered statistically significant.
Study III: Paired samples t-test, Wilcoxon signed rank test, Spearman’s cor-
relation test, Fisher’s test, and regression analysis were used, as appropriate, 
for statistical analysis (SPSS for Windows, version 13.0, SPSS, Chicago, USA). 
The mean measurement values of the two matched controls for each patient 
were used in paired analyses; the results were considered significant when 
paired samples t-test and Wilcoxon signed rank test both agreed.
Study IV: Independent samples t test, Mann-Whitney-U, Fischer’s exact test, 
Tukey post hoc test, and one way analysis of variance (ANOVA) tests were 





6.1. Clinical and genetic findings
Seventeen Finnish patients who fulfilled the clinical diagnostic criteria 
for SDS participated in the study. There were two sets of siblings. The 
age range of the patients at the study entry was 2.1-37.0 years (mean 
age 17.4 years). Eleven out of the 17 patients (65 %) were males. The 
age of diagnosis of SDS ranged from 4 months to 14.5 years. All except 
the four patients diagnosed after 5 years of age had started pancre-
atic enzyme substitution at the time of the diagnosis, and all patients 
had suffered from recurrent infections in infancy. Eleven patients had 
neutropenia (neutrophil count <1500 x106/L), and three of them had se-
vere neutropenia (neutrophil count <500 x106/L). Three had subnormal 
hemoglobin levels (age-dependent), and three had thrombocytopenia 
(thrombocyte count <150 x106/L). In one patient all three cell lines were 
affected. None of the patients had evidence of MDS or malignant bone 
marrow transformation at the time of the study.
The radiographic assessment showed several bone abnormalities such 
as expansion of costochondral junctions and rib cage narrowing (Figure 
3 A-C), metaphyseal changes in the wrists, hips, and the knees (Figure 3 
D-H), and delayed bone age (Figure 3 H-K). Two patients had undergone 
surgery due to limb deformities caused by metaphyseal dysplasia; one of 
them had had hemiepihyseodesis of the knee because of genu valgum 
(Figure 3 G), the other bilateral femoral osteotomy because of Legg-
Calvé-Perthes disease of the hips. 
Genetic analysis revealed mutations in SBDS in twelve patients. Nine pa-
tients were compound heterozygotes for the two common SBDS muta-
tions 258+2T>C and 183TA>CT. Three additional patients were hetero-
zygous for 258+2T>C; a second mutation was identified on the other 
allele in two of these patients. In the third patient, no mutations could 
be identified by complete gene sequencing of the second allele. In five 
patients, complete gene sequencing failed to identify any SBDS muta-




FIGURE 3. Skeletal radiographic features of Shwachman-Diamond syndrome.
A-B. Short ribs with marked cupping and widening of the anterior ends in chest X-ray at 11 months. 
C. CT slice shows narrow and deformed rib case, as well as cupping and irregular widening of the costochondral 
junctions. 
D. Broad pelvis, short iliac notches, horizontal acetabuli, and wide proximal metaphyses of the femora are noted 
in pelvic X-ray at 11 months. 
E. X-ray of the lower limbs at 6 months shows mild bowing of the femoral shafts, metaphyseal widening in the 
proximal and the distal femora and tibiae, and cupping in the distal metaphyses of the tibiae and the fibulae. 
Femoral necks are short and in valgus position. 
F-G. Marked metaphyseal changes with striated abnormal bony structure in the hips and the knees at 14 years. 
Medial hemiepiphyseodesis was performed on the right distal femur because of genum valgum. 
H-I. Delayed bone age at 11months with missing ossification of the carpal (H) and tarsal (I) bones. The middle 
phalanges in the 5th fingers (MP V) are short and the wrist metaphyses are irregular. 
J-K. The hand radiograph at 4.5 years (J) shows markedly delayed bone maturation particularly in the carpal 
bones, and short MP V.  At 11 years (K), the bone age of the same patient is slightly delayed, and MP V has grown 
in length. 






























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.2. Study I: Pancreatic biochemistry and imaging 
findings in patients with clinical diagnosis of 
Shwachman-Diamond syndrome
Altogether fourteen patients (10 males, 2.1 – 37.0 years) were included: 
eleven had prospective abdominal MRI and three children had under-
gone MRI for clinical indications. Two children were too young to un-
dergo MRI without anesthesia, and parental consent was lacking for one 
child: these three patients were thus excluded from the study cohort. 
At the time of the study, three patients, all with different mutations in 
SBDS, were pancreatic insufficient based upon S-trypsinogen levels. Four 
patients, three with SBDS mutations and one without any mutations, 
had intermediate values. In the remaining six patients, values were with-
in normal range (not assessed in one).
At the study assessment, all SBDS mutation-positive patients except 
one had neutropenia, and all had low serum isoamylase levels. On MRI, 
all patients with SBDS mutations had small to normal size fat-replaced 
pancreas with occasional scattered enhancing foci of pancreatic paren-
chyma, and subtle enhancement along the pancreatic duct (Figure 4 A-
F). With the exception of the patient previously diagnosed with type 1 
diabetes mellitus, the endocrine function of the pancreas, based upon 
HbA1c measurements, was normal in mutation-positive patients.
All five SBDS mutation-negative patients had normal neutrophil counts 
at the time of the study assessment. MRI demonstrated normal pancre-
atic anatomy and parenchyma without fatty infiltration (Figure 4 G) in 
four patients, and a rare pancreatic anomaly (agenesis of dorsal pancreas 
with associated polysplenia) in an adolescent who was investigated due 
to a clinical suspicion of SDS (Figure 4 H). Serum pancreatic isoenzyme 
levels were normal in the mutation-negative patients, except for the 
patient with a rare developmental anomaly of the pancreas. Endocrine 




FIGURE 4. Pancreatic MRI findings in patients with a clinical diagnosis of 
Shwachman-Diamond syndrome. 
A-B. In a 2-year-old SBDS-positive patient, T1 FFE (A; TR 3.35 ms, TE 1.67 ms, 5 mm 
slice) and T2 fs (B; TR 1200 ms, TE 70 ms, 5 mm slice) images at the level of the pancre-
atic body and tail show fatty replacement of the pancreas.
C-E. In a 33-year-old SBDS mutation-positive patient, in-phase (C; TR 100 ms, TE 5.04 
ms, flip angle 70°, 5 mm slice) and out-of-phase (D; TR 100 ms, TE 2.38 ms, flip an-
gle 70°, 5 mm slice) images demonstrate small, lipomatous pancreas. Gadolinium-
enhanced (Gd) T1 fs (E; TR 3.35 ms, TE 1.67 ms, 5 mm slice) image shows scattered 
parenchymal enhancement particularly in the tail of the pancreas.
F. Enhancing duct (arrows) within a small fat-replaced pancreas in a 31-year-old patient 
with SBDS mutations (Gd T1 fs, TR 3.35 ms, TE 1.67 ms, 5 mm slice).
G. Normal pancreatic anatomy and structure in a 24-year-old mutation-negative patient 
(Gd T1 fs, TR 3.35 ms, TE 1.67 ms, 5 mm slice).
H. Pancreatic head (long arrow) but missing body and tail and one of the multiple 
spleens (arrowhead) are demonstrated in the abdominal T2 fs (TR 1200 ms, TE 70 ms, 5 
mm slice) image in a 13-year-old patient without mutations in SBDS. The imaging find-
ings are consistent with polysplenia-dorsal pancreas agenesis anomaly.
6.3. Study II: Radiographic, bone mineral density, 
and bone histomorphometry findings in SBDS mu-
tation-positive patients with Shwachman-Diamond 
syndrome
All eleven SBDS mutation-positive patients (8 males, 5.2 – 37.0 years) that 
fulfilled the inclusion criteria participated. The median height Z-score at 
the time of the study was -2.3, ranging from -3.1 to -0.7. None of the 
patients had motor disabilities and their physical activity was considered 
normal. Nine patients had received pancreatic enzyme supplements, and 
eight had been given supplementation for vitamin D, six for vitamins E 
and A, and two for calcium. One patient had sustained a vertebral frac-
ture after a low-energy fall, and three patients had sustained periph-
eral fractures; the fracture sites being the wrist, the hip and the femoral 
shaft.
Blood biochemistry suggested mild deficiencies of vitamin D (median 
37 nmol/L, range 17 - 76 nmol/L) and vitamin K (median 73%, range 58 
- 109%). Serum concentrations of vitamins E and A and plasma levels of 
Ca, Pi and alkaline phosphatase were normal in all patients. Three pa-
tients had hyperparathyroidism, interpreted to be secondary to vitamin 
D deficiency in two patients. In the third patient, the cause of hyperpara-
thyroidism remained unknown.
In spinal radiographs three patients had altogether eight compressed 
vertebrae, all in the thoracic spine. Three patients had scoliosis and one 
had kyphosis. BMD Z-scores (Figure 5) were significantly reduced at the 
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lumbar spine (median -2.1, ranging from -4.4 to -0.8), the proximal fe-
mur (median -1.3, ranging from -2.2 to -0.7), and at the whole body 
(median -1.0, ranging from -2.8 to 0.6). Lumbar BMD Z-score was below 
-2.0 SD in 63% of the patients. The median height-adjusted BMC/LTM 
Z-score was -0.9, ranging from -3.6 to 1.1. Four out of five adults had 
BMD T-scores suggestive of osteopenia (T-score < -1.0) or of osteoporosis 
(T-score <-2.5). No correlation was observed between neutrophil levels 
and any of the bone density values
FIGURE 5. Bone densitometry in Shwachman-Diamond syndrome.
Low bone density in the lumbar spine and the femoral neck
A-B. in a 5-year-old patient with pancreatic enzyme supplementation from age 18 months.
C-D. in a 14.5-year-old patient without any pancreatic enzyme supplementation.
E-F. in a 26-year-old patient with pancreatic enzyme substitution from age 4 months.
Bone biopsy was performed on four patients (age range 14.6 – 31.1 
years). Three samples were suitable for histomorphometric analysis. 
Bone trabecular structure was broken in the biopsy material of the 
fourth patient who had the most severe osteoporosis based on BMD 
values (Figure 5 E-F) making it impossible to perform complete histo-
morphometric analysis. Both osteoblasts and osteoclasts were reduced 
in number in all bone biopsy samples, but mineralization of osteoid was 
deemed normal. Three technically optimal samples all showed reduced 
amounts of osteoid and low bone turnover. Histomorphometric findings 
typical of osteomalacia were not observed in any of the bone samples.
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6.4. Study III: Brain magnetic resonance imaging 
findings in patients with Shwachman-Diamond syn-
drome and SBDS gene mutations
Nine consenting SBDS mutation-verified patients (7 males, 7 - 37 years) 
that fulfilled the inclusion criteria were included in the study. The auxo-
logical data on height and OFC at birth, at the age of 1 year, and at study 
assessment are presented in Table 6. Patients with SDS had smaller head 
circumferences than the controls (mean OFC Z-score -1.3 vs. +0.3). In a 
subset of patients, head circumferences had already been small at birth 
(mean OFC Z-score -0.9, range -2.5 - 0.3) and in early infancy (mean OCF 
Z-score at the age of 1 year -1.0, range -2.0 - 0.0), but no consistent pat-
tern of OFC growth during development was noted. 
TABLE 6. Height and OFC Z-scores at birth, at age 1 year, and at study assessment. 
OFC, occipitofrontal circumference; na, not available.
According to parent reports, five patients had had delayed speech or 
motor development, or of both. Compared to their healthy siblings, the 
majority had lower academic achievement. Eight out of nine patients 
had learning difficulties, mathematics and foreign languages were the 
most challenging subjects at school. Two patients had undergone neu-
ropsychological evaluation due to significant learning difficulties. Four 
patients had received special education services.
Visual assessment of the brain MRI was considered normal in all patients 
with SDS and the controls. Global brain volume was smaller in patients 
with SDS than in controls (1.74 L vs. 1.94 L, P = 0.019), both gray matter 




volumes were reduced. In voxel-based analysis, regional brain matter 
volume changes failed to reach significance. Midsagittal measurements 
revealed that posterior fossa (35.6 cm2 vs. 43.5 cm2, P <0.0001) and cere-
bellar vermis (10.1 cm2 vs. 12.5 cm2, P = 0.002), corpus callosum (5.5 cm2 vs. 
6.7 cm2, P = 0.010), and brain stem (4.1 cm2 vs. 5.13 cm2, P <0.0001) were 
structurally smaller in patients with SDS than in the healthy controls. The 
ratios of cerebrum/vermis (15.1 vs. 9.99, P <0.0001) and cerebrum/corpus 
callosum (21.1 vs. 18.7, OFC-adjusted P <0.029) were increased. 
6.5. Study IV: Myocardial function and imaging 
findings in patients with SBDS mutation-verified 
Shwachman-Diamond syndrome
Eight consenting patients that fulfilled the inclusion criteria were includ-
ed in the study. The mean age at the time of the study was 24.1 years 
(range 7-37 years). Clinical cardiac and echocardiographic assessment 
was performed on all the patients, and exercise tissue Doppler exami-
nation was performed on all except the youngest patient who was too 
small to reach the ergometer pedals. Six adult patients (5 males, mean 
age 28 years, range 17-37 years) underwent the cardiac MRI protocol.
None of the patients had cardiac symptoms prior to or at the time of the 
study. The patient with type 1 diabetes mellitus had hypertension; he 
was treated with enalaprin and insulin. Other patients were normoten-
sive and had not received cardiac medication. The 37-year-old male had 
two siblings who had succumbed to SDS and cardiac failure as neonates; 
in one of them, autopsy had shown myocardial necrosis (Savilahti & 
Rapola, 1984).
No abnormalities in cardiac anatomy or function were observed at base-
line clinical assessment. All patients had sinus rhythm and normal pa-
rameters on ECG. Conventional echocardiographic measurements were 
within normal range in all of them. In tissue Doppler examination dur-
ing exercise, maximum isovolumic acceleration value was significantly 
lower in patients with SDS (3.6 cm/sec2 vs. 8.1 cm/sec2, P < 0.001) than in 
controls; no differences were noted in S-wave velocities between these 
groups.
Myocardial structure assessed with MRI was normal in patients with SDS, 
and left ventricular mass did not differ from that of the controls. No 
evidence of myocardial fibrosis was noted in late-enhancement con-
trast-enhanced MRI images. Atrial functions and left ventricle systolic 
and diastolic parameters were normal. On MRI, the mean right ventricle 
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ejection fraction (66% vs. 58%, P = 0.02) and the mean right ventricle 
peak filling rate (520 ml/s vs. 320 ml/s, P = 0.008) as well as the mean left 
ventricle peak filling rate (520 ml/s vs. 410 ml/s, n.s) at rest were higher 




The recent discovery of disease-causing mutations in the SBDS gene has 
opened new insight into the pathogenetic and molecular mechanisms 
behind SDS. The clinical presentation of this pleiotropic disorder has ap-
peared more diverse and complex than previously believed. Careful eval-
uation of a genetically verified group of patients may reveal previously 
unrecognized features and expand our understanding of the full phe-
notypic spectrum of SDS. Accordingly, this study was able to character-
ize novel phenotypic features of SDS such as low-turn-over osteoporosis 
and structural brain alterations, both of which are likely to have clinical 
implications for patients with this disease.
7.1. Study I: Pancreatic phenotype in Shwachman-
Diamond syndrome 
In the present study, abdominal MRI proved to be an accurate method 
in differentiating patients with true SDS and SBDS mutations from those 
with an SDS-like phenotype but no identifiable mutations in the SBDS 
gene. At the time of the diagnosis, all five of our mutation-negative pa-
tients had a typical presentation of SDS with exocrine pancreatic insuf-
ficiency and neutropenia, yet no mutations in the SBDS gene were de-
tected at the time of this study. Clinically, the normalization of pancre-
atic function over time was similar in patients with and in those without 
mutations in SBDS but the MRI findings differed significantly between 
these two groups. In line with previous observations on SDS patients 
without genotypic verification (Ip et al. 2002), the pancreatic phenotype 
in patients with SBDS mutations was characterized biochemically by con-
stantly low serum pancreatic isoamylase levels. MRI invariably showed a 
fat-replaced pancreatic gland with occasional scattered foci of paren-
chyma and enhancement of the pancreatic duct, regardless of variable 
clinical exocrine pancreatic sufficiency state.
Patients with SDS phenotype but with no mutations in the SBDS gene 
had normal pancreatic structure and parenchyma without any fat accu-
mulation in the gland. In one SBDS mutation-negative patient, MRI was 
able to reveal a rare developmental pancreatic anomaly of heterotaxy 
syndrome group. All other SBDS-negative patients had normal levels of 
serum pancreatic isoamylase.
Sonography, considered the primary imaging modality for children, can 
provide evidence of lipomatosis but its visibility may be compromised, 
especially in infants (Nijs, Callahan & Taylor 2005). Furthermore, due to 
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operator-dependency, hyperechogenic pancreas may be overlooked, es-
pecially if the sonographer is unaware of the clinical suspicion of SDS 
(Adachi et al. 2005). Accordingly, in the present study, a retrospective 
image analysis of sonographic examinations performed prior to or at the 
time of diagnosis showed in a large proportion of patients hyperecho-
genic pancreas that had primarily been reported normal. CT can reliably 
demonstrate pancreatic lipomatosis (Bom et al. 1993, Robberecht et al. 
1985) but the associated heavy radiation load makes it less advisable in 
children - even more so in this specific group of patients known to have 
high propensity for malignant bone marrow transformation. MRI pro-
vides a useful tool for pancreatic imaging (Pamuklar & Semelka 2005). 
With standard abdominal MRI sequences, it was possible to reliably dif-
ferentiate the SDS patients with SBDS mutations from the mutation-
negative patients. Furthermore, MRI may reveal differential diagnostic 
alternatives, as was demonstrated by the detection of a rare pancreatic 
anomaly in one patient. Therefore, it is advisable to include abdominal 
MRI in the clinical diagnostic work-up of children with unexplained exo-
crine pancreatic dysfunction.
Endocrine pancreatic function was affected in only one patient; a male 
with a combination of one common mutation and one complex muta-
tion in SBDS was diagnosed with type 1 diabetes at age 15. SDS has occa-
sionally been associated with type I and type II diabetes, even neonatal-
onset diabetes has been reported (Shmerling et al. 1969, Aggett et al. 
1980, Mack et al. 1996, Ginzberg et al. 1999, Filippi et al. 2002, Mäkitie 
et al. 2004, Kawakami et al. 2005, Kamoda et al. 2005, Kawashima et al. 
2006, Rosendahl et al. 2006). The association of SDS and diabetes is pres-
ently obscure, but it is possible that in the future deeper understanding 
of the SBDS protein function in pancreatic cells may shed light on new 
potential pathogenetic mechanisms in diabetes. 
The mechanisms and the time of acinar cell damage – or lack of cell 
development – in SDS that results in pancreatic lipomatosis as well as 
the apparent improvement of exocrine pancreatic function later in life 
remain unclear. Imaging and histopathology have shown fatty pancreas 
even in infancy. Hitherto, there is no evidence of in utero presentation 
of pancreatic lipomatosis in SDS. On the other hand, evidence of normal 
pancreatic tissue conversion into fat is currently also lacking. The pancre-
as is composed of endocrine and exocrine (ductal and acinar) compart-
ments, but during embryonic development all pancreatic cells differenti-
ate from ductal epithelium. Adult ductal epithelium retains its ability to 
give rise to all cell types of the pancreas, and it has been suggested that 
the main progenitor source for pancreatic growth and regeneration are 
the mature duct cells that have regressed or dedifferentiated (Bonner-
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Weir et al. 2004). The exocrine pancreas has a large functional capacity; 
only 2-10% of residual function suffices to render patients clinically pan-
creatic sufficient (DiMagno, Go & Summerskill 1973, Gaskin et al. 1984). 
Whether the small foci of enhancing parenchyma in SDS patients repre-
sent preserved acini or foci of regeneration remains to be addressed in 
future studies. The observed duct enhancement in some of our patients 
demonstrates the presence of duct cells. Preservation of the duct and is-
let cells, and the absence of irreversible pancreatic fibrous degeneration 
may explain the recovery of the exocrine pancreatic function over time. 
7.2. Study II: Expansion of the skeletal phenotype in 
Shwachman-Diamond syndrome 
The findings of the present study expand the spectrum of SDS-related 
bone disease, in addition to earlier recognized metaphyseal chondrod-
ysplasia, to include early-onset low-turnover osteoporosis. We were able 
to show that the skeletal phenotype of SDS is more complex than previ-
ously believed and that not only chondrocytes in growth plates but also 
osteoblasts and osteoclasts are involved.
The present study showed low bone density in all patients with SBDS mu-
tation-verified SDS. The associated history of low-impact fractures with 
vertebral compression deformities in some patients suggests true im-
pairment of bone quality. Bone biopsy findings with reduced trabecular 
bone volume, low numbers of osteoclasts and osteoblasts, and reduced 
amount of osteoid further indicate low turn-over osteoporosis. Bone bi-
opsy results differ from bone histomorphometry findings in cystic fibro-
sis, which have shown decreased osteoblastic but increased osteoclastic 
activity (Haworth et al. 2000). All SBDS mutation-positive patients had 
consistently decreased bone density, indicating that osteopenia/oste-
oporosis is a universal feature of this disorder. According to bone biopsy 
findings, osteoporosis results from a primary defect in bone metabolism 
and not from any nutritional deficiencies. However, suboptimal levels of 
vitamin D and K, noted in a large proportion of patients in the present 
study, may further impair bone quality in these patients. 
Low-turnover osteoporosis with reduced numbers of both osteoclasts 
and osteoblasts may be directly related to the SBDS defect in stem cell 
proliferation or differentiation. Macrophages, osteoclasts, and neu-
trophils have a common precursor stem cell, the granulocyte/macro-
phage colony-forming cell. Thus, the reduced number of osteoclasts and 
neutropenia in SDS may be due to marrow hypofunction at the stem cell 
level. The level of expression and the role of SBDS in bone and in various 
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cell types required for normal bone formation and turnover are currently 
unknown. The role of the SBDS protein in the function of chondrocytes, 
osteoblasts, osteoclasts and their precursors thus needs to be elucidated 
in further studies. While no therapeutic means to target the primary 
defect are presently available, efforts should be made to optimize gen-
eral preventive measures such as nutrition and intake of fat-soluble vita-
mins, as well as to promote weight-bearing exercise. Although vitamin 
D deficiency is not the underlying cause for impaired bone health in 
SDS, low vitamin D values in a significant number of patients indicate 
that vitamin substitution was not optimal; higher doses of substitution 
should be used in these patients in order to prevent further impairment 
of bone quality.
7.3. Study III: Structural brain alterations in 
Shwachman-Diamond syndrome 
Despite the evidence for mild neuropsychological dysfunction associated 
with SDS, previous systematic neuroimaging studies have not been per-
formed. This study was able to demonstrate that patients with muta-
tion-verified SDS had formerly unrecognized structural brain changes in 
the cerebellum and in the corpus callosum. 
The majority of the patients in the present study had a small head cir-
cumference, although only two were microcephalic. Microcephaly was 
less frequent in the present study than in the only previous systematic 
study on SDS with OFC-assessment where half of the patients had head 
circumference below third percentile (Aggett et al. 1980). The head size 
was independent of SBDS genotype and ranged from a severely small 
head (-4.3 SD) to normal OFC (+1.3 SD). In line with an overall small head 
circumference, patients had smaller global brain volume: both white and 
gray matters were equally decreased. At birth, human brain size is one 
fourth of its adult volume and reaches three fourths of its final volume 
by the end of the first year. Small head size has been associated with 
several syndromes presenting with psychomotor retardation. Moreover, 
among children evaluated for developmental disabilities, many with 
normal or borderline IQ, microcephaly is a common finding (Watemberg 
et al. 2002). In the present study, no consistent pattern of head growth 
reduction was observed: some of the patients had small OFC already at 
birth, while in some patients with normal OFC at birth small head size 
was, however, evident at a later age.
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In the present study, all except one patient reported learning difficul-
ties and they had distinctively lower academic achievement than their 
siblings. Only two, however, had undergone formal neuropsychologi-
cal evaluation. It appears that cognitive impairment is present in the 
majority of the patients but it is usually mild and often unrecognized. 
Therefore, only a few patients are referred to neuropsychological evalu-
ation. It is possible that the two patients who had undergone neuropsy-
chological testing represented the more severe end in the neuropsycho-
logical phenotype of this variable disorder. Possibly, in order to recog-
nize mild cognitive disabilities, all children with SDS would benefit from 
formal neuropsychological evaluation. Subsequently, some of them may 
require special education services at school.
In voxel-based morphometry analysis, the method that has uncovered 
subtle changes in various brain regions in different patient groups 
(Ashburner et al. 2003), no significant focal alterations in gray or white 
matter were noted in patients with SDS. Failure to identify regional ab-
normalities may be due to the small cohort size. Midsagittal areal meas-
urements, however, revealed significantly smaller callosal and posteri-
or fossa structures in SDS patients, even when adjusted for head size. 
Several studies have demonstrated the role of the cerebellum in higher 
cognitive functions, including visuospatial task performance, verb gen-
eration, and verbal working memory (Paradiso et al. 1997, Schmahmann 
& Sherman 1998, Cabeza & Nyberg 2000). Posterior fossa malformations 
and volumetric or structural abnormalities of the cerebellum or vermis 
have been associated with developmental and cognitive problems in 
several syndromes (Tavano et al. 2007). Small corpus callosum has been 
described in children with learning impairment after perinatal adverse 
events (Njiokiktjien, de Sonneville & Vaal 1994), and in fetal alcohol syn-
drome (Autti-Rämö et al. 2002). The vermis develops after fusion of cer-
ebellar hemispheres by the end of the 15th gestational week; rapid cer-
ebellar growth occurs at late gestation (Limperopoulos et al. 2005). The 
development of corpus callosum occurs between the 3rd and 5th months 
of pregnancy, but the thickening of corpus callosum is completed only 
after birth. It is unclear whether the observed alterations in brain struc-
tures in SDS result from changes in prenatal development or only after 
birth. Therefore, fat malabsorption and serious infections at an early 
age may also play a role in brain growth and cognitive function in SDS. 
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7.4. Study IV: Myocardial function in Shwachman-
Diamond syndrome 
The previous fatal myocardial complications in Finnish infants with SDS 
(Savilahti & Rapola 1984) and excessive stem cell transplantation-related 
cardiac toxicity, more recently reported, prompted us to study whether 
patients with SDS show signs of myocardial damage or other cardiac 
manifestations. All assessed patients with mutation-verified SDS had 
normal myocardial structure and left ventricle mass. None of them had 
evidence of myocardial fibrosis, when assessed by a sensitive method of 
late-enhancement cardiac MRI (Hunold et al. 2005). This finding, togeth-
er with the lack of reports on myocardial necrosis in SDS during the past 
two decades, suggests that the necrotic and fibrous cardiac lesions are 
not common manifestations in SDS. It is possible that the combination 
of inadequate nutrition and serious infections may have contributed to 
the fatal neonatal outcome with myocardial necrosis and fibrosis in the 
early reports.
However, we observed some abnormalities in the dynamic properties of 
myocardial function in patients with SDS and mutations in SBDS. Tissue 
Doppler echocardiography, which measures the left ventricle systolic 
wall movement velocity during ejection phase and myocardial accelera-
tion during isovolumic contraction was used to assess the reserve con-
tractile capacity of the myocardium. Isovolumic acceleration has been 
shown to reflect contractility (Vogel et al. 2003, Cheung et al. 2005). 
Unlike conventional indices of systolic function, tissue Doppler may offer 
data that are more sensitive to early alterations in left ventricle function. 
In the present study, a significantly reduced maximum isovolumic accel-
eration value, but not systolic wall movement, was noted in the patients. 
On the other hand, three-dimensional analysis of the MRI data showed 
that both left and right ventricle peak filling rates were increased in 
patients with SDS, although a significant change was noted only in the 
right ventricle peak filling rate. The aforementioned observations on 
isovolumic acceleration suggest that the left ventricular contractile re-
serve may be depressed, whereas increased peak filling rate as a sign of 
diastolic dysfunction is commonly observed in mildly restrictive cardio-
myopathy. In cardiomyopathies in general, diastolic dysfunction usually 
precedes systolic disturbances, and right ventricle dysfunction becomes 
evident prior to left ventricular changes (White & Patel 2007). Similarly, 
diastolic alterations in the right ventricle were noted in the present 
study. Considering all these data, young SDS patients without clinical 
cardiac manifestations have subtle changes in myocardial properties. 
These findings that possibly represent a hitherto occult cardiac involve-
ment may deserve careful attention in future clinical studies.
DISCUSSION
58
Observed alterations, in combination with the earlier reports of myo-
cardial involvement and the reported cardiac toxicity during stem cell 
transplantation, raise the question whether patients with SDS have myo-
cardial properties that predispose them to cardiac complications in ex-
treme conditions. The use of cardiotoxic conditioning regimens such as 
cyclophosphamide and total body irradiation may further increase the 
risk of cardiac disturbances in patients with SDS. 
7.5. General discussion
Although SDS classically presents during the first years of life with steat-
orrhea, neutropenia, and skeletal changes, it is important to emphasize 
that patients with SDS may be recognized well beyond childhood with 
symptoms less characteristic than in those diagnosed at an early age. As 
the typical gastroenterological symptoms may be mild and even disap-
pear after infancy in a significant number of patients, the diagnostic 
work-up becomes more challenging. Due to the intermittent nature of 
neutropenia, hematological presentation may be clinically confusing. 
Phenotypic variability even within a family may further avert the clini-
cian from the correct diagnosis. 
During the present study, three new patients were diagnosed with SDS. 
A child presented at the age of 2 with classical symptoms of pancreatic 
insufficiency, neutropenia, recurrent infections and skeletal dysplasia. 
Another patient, a clinically asymptomatic 6-year-old boy, was recog-
nized to have SDS when his 17-year-old brother who was diagnosed 
with SDS in infancy participated in the present study; both brothers had 
the same genotype. The third patient, a 14-year-old boy, was referred 
to further investigations by an orthopedic surgeon because of knee de-
formities and metaphyseal changes. In addition to these three patients, 
another patient, a 13-year-old girl who was referred to investigations 
because of neutropenia and low fecal elastase values had an extremely 
rare pancreatic developmental anomaly that clinically mimicked SDS. 
Since two of the patients diagnosed during the study presented without 
characteristic symptoms of SDS there is a strong possibility that there are 
additional unrecognized SDS patients in Finland. Moreover, the patients 
illustrate the large phenotypic and genotypic spectrum of SDS. The iden-
tification of these patients enables correct support and treatment for 
the variable symptoms and organ involvement in SDS. Furthermore, a 
correct diagnosis can effectively alleviate parental anxiety in families 




No genotype-phenotype correlations have been observed in skeletal 
dysplasia (Mäkitie et al. 2004) or in hematological features (Kawakami 
et al. 2005, Kuijpers et al. 2005) in SDS. The finding of two patients with 
mutations in SBDS gene and with severe bone disease expands the skel-
etal phenotypic spectrum from usually mild to moderate bone changes 
to its severest end with phenotypic resemblance of neonatal spondylom-
etaphyseal dysplasia (Nishimura et al. 2007). Our results were similar: 
no genotype-phenotype correlation was noted regarding osteoporosis 
and neuroradiological aspects. Phenotypic features have been shown to 
change over time. Despite the invariable imaging finding of lipomatosis, 
pancreatic dysfunction becomes clinically insignificant in a large propor-
tion of patients. However, osteoporosis is likely to result in significant 
clinical sequelae over time. Since long-term follow-up on cardiac fea-
tures is lacking, it is unclear whether patients with SDS develop clinically 
relevant cardiac manifestations at a later age.
As some of the clinical features of SDS, such as hematological dysfunc-
tion, require regular follow-up, accurate recognition and correct diag-
nosis of this disorder is of utmost importance. SBDS mutation-negative 
SDS appears to have better prognosis at least regarding hematological 
and pancreatic presentations. Future studies may be able to recognize 
new genetic defects behind the described SDS phenotype without muta-
tions in SBDS.  
The versatile exploitation of imaging modalities, and the use of advanced 
specialized imaging methods for different organ systems in genetically 
defined patient groups provide useful tools for the characterization of 
novel phenotypic features. This approach could thus potentially increase 
the ethiopathogenetic understanding in various disease entities.
Limitations of the study
The major limitations of our study are the small number of the patients 
and their wide age range. Due to the limited number of patients and 
of controls, the possibility of statistical errors cannot be excluded. It is 
possible that, due to the variable ages of the subjects and the small size 
of our cohort, some brain and myocardial alterations failed to reach sig-
nificance. The present study protocol did not include neuropsychological 
testing because the main focus of the study was on the imaging find-
ings. In retrospect, neuropsychological data would have been of interest 
and of importance. The cardiac imaging studies of the patients and of 
the controls were performed at different times and cardiac MRI with 
varying equipment, nor were we able to match the groups for age, gen-
der, or height. 
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7.6. Prospects of future research 
Our observations of primary osteoporosis and morphological brain 
changes in SDS should be re-examined in larger patient cohorts in order 
to validate the consistency of the findings in the general SDS population 
and to better enable the assessment of potential phenotype-genotype 
correlations. Characterization of the neuropsychological phenotype in 
SDS is of utmost importance for the patients in order to provide them 
with appropriate support and therapy for cognitive challenges. Mild 
functional myocardial alterations warrant assessment in larger patient 
groups with longitudinal follow-up in order to elucidate whether these 
alterations evolve over time and whether a distinct cardiac SDS pheno-
type exists. 
At the moment, in about 5-15% of subjects with clinical findings of SDS, 
mutations cannot be found, even after extensive laboratory testing. It 
is possible that further studies may reveal additional genes that result 
in clinical SDS. Genetic testing, presently available, will allow for char-
acterization of the full clinical spectrum of SDS. Future studies may shed 
light on the role of defective SBDS protein and whether heterozygous 
mutations in SBDS are involved in the pathogenesis of multigenic disor-
ders in the general population. 
Animal models of SDS can be used to investigate processes in the af-
fected organs such as the pancreas, the liver, bone marrow and the 
skeleton. Furthermore, the understanding of the essential role of SBDS 
in ribosomal biogenesis may provide information on the pathophysiol-
ogy of pancreatic and skeletal diseases, hematopoietic dysfunction and 
malignant bone marrow transformation. Finally, the elucidation of the 
underlying impairment in biological pathways could allow for the devel-




Wide phenotypic variation, unrelated to genotype, was observed in the 
study subjects. Clinical presentation varied with age. Since the present-
ing symptoms are often atypical, a significant number of patients with 
SDS may escape correct diagnosis.
The study demonstrated that abdominal MRI can reliably differenti-
ate between SBDS mutation-positive and mutation-negative patients 
among the Finnish patients with a clinical diagnosis of SDS. In addition, 
MRI may provide valuable information on differential diagnostic alter-
natives. Therefore, abdominal MRI should be included in the evaluation 
of children with exocrine pancreatic insufficiency.
The present study was able to expand the SDS phenotype to include low-
turnover osteoporosis and structural brain alterations.
The study showed that SDS in patients without cardiac symptoms is not 
associated with major cardiac involvement or myocardial fibrosis but 
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